Shamroha Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 4 Months
- Last Filing with ROC 31 Mar 2019
About Shamroha Lifesciences
Shamroha Lifesciences Private Limited (SLPL) is a Private Limited Indian Non-Government Company incorporated in India on 03 October 2018 (Six years and four months 22 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Vikul Bansal, Rishav Jain, Veena Jolly, and One other member serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U52311DL2018PTC340018
- Company No.
340018
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Oct 2018
- Date of AGM
31 Dec 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Shamroha Lifesciences?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vikul Bansal  | Director | Current | |
| Rishav Jain | Director | 22-Jul-2021 | Current |
| Veena Jolly | Director | Current | |
| Deshbir Singh | Director | 10-Mar-2021 | Current |
Financial Performance of Shamroha Lifesciences.
Enhance accessibility to Shamroha Lifesciences's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Shamroha Lifesciences?
In 2019, Shamroha Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sysmed Exim Private LimitedVeena Jolly is a mutual person
Damaira Pharmaceuticals Private LimitedVikul Bansal is a mutual person
- Edelmanas Healthcare Llp
Veena Jolly is a mutual person
- Sysmed Medical Technologies Private Limited
Veena Jolly is a mutual person
- Sysmed Poct Private Limited
Veena Jolly is a mutual person
- Sysmed Infra Private Limited
Veena Jolly is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Shamroha Lifesciences?
Unlock and access historical data on people associated with Shamroha Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shamroha Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shamroha Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.